WEST LAFAYETTE, Ind. — Cold atmospheric plasma technology, currently the only way to remove microscopic cancer tumors remaining from surgery, has been approved by the U.S. Food and Drug Administration ...

TAKOMA PARK, Md.--(BUSINESS WIRE)--The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI) and US Medical Innovations, LLC (USMI) announced today that the full ...

It's been a few months since the world was focused on convalescent plasma – the idea that the antibody-rich plasma extracted from the blood from recovered Covid-19 patients could help treat the sick.

As the government works double-time alongside companies to test and manufacture an effective vaccine for the coronavirus, researchers examine other drugs and treatments for COVID-19, the illness ...

A new analysis finds therapeutic plasma exchange has become more costly, and more common among patients with multiple myeloma. Therapeutic plasma exchange (TPE) has become more common in patients with ...

Takeda’s (NYSE: TAK) (TSE:4502) plasma-derived therapies (PDT) business, led by Giles Platford, president of Takeda’s Plasma-Derived Therapies Business Unit and chair of the Plasma Protein ...

A team of scientists from France has recently demonstrated the efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma therapy in improving the survival rate among patients with B-cell ...